Rick Pauls
2017
In 2017, Rick Pauls earned a total compensation of $502K as President and Chief Executive Officer at DiaMedica Therapeutics.
Compensation breakdown
| Bonus | $36,667 |
|---|---|
| Option Awards | $167,738 |
| Salary | $280,000 |
| Other | $17,550 |
| Total | $501,955 |
Pauls received $280K in salary, accounting for 56% of the total pay in 2017.
Pauls also received $36.7K in bonus, $167.7K in option awards and $17.6K in other compensation.
Rankings
In 2017, Rick Pauls' compensation ranked 11,854th out of 14,666 executives tracked by ExecPay. In other words, Pauls earned more than 19.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,854 out of 14,666 | 19th |
Division Manufacturing | 4,666 out of 5,772 | 19th |
Major group Chemicals And Allied Products | 1,702 out of 2,075 | 18th |
Industry group Drugs | 1,412 out of 1,731 | 18th |
Industry Pharmaceutical Preparations | 1,104 out of 1,333 | 17th |
Source: SEC filing on April 8, 2019.
Pauls' colleagues
We found one more compensation record of an executive who worked with Rick Pauls at DiaMedica Therapeutics in 2017.
2017
Todd Verdoorn
DiaMedica Therapeutics
Chief Scientific Officer
News
DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
April 4, 2024
DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
April 4, 2023
DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
April 5, 2022
DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
April 20, 2020
DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
April 8, 2019